Pain-predominant disorders of gut-brain interaction (DGBIs) in children -; such as functional abdominal pain (FAP) and irritable bowel syndrome (IBS)-; can lead to disabling symptoms, poor quality of life and high use of health care resources. Studies suggest that an open-label placebo (OLP) approach -; in which patients are aware that they are receiving a